Patent details

Basic Information

Publication number:

EP0839040

PCT Application Number:

PCT/EP/1996/003024

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP969239854

PCT Publication Number:

WO/1997/003675

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF CGMP-PHOSPHODIESTERASE INHIBITORS TO TREAT IMPOTENCE

French Title of Invention:

UTILISATION D'INHIBITEURS DE PHOSPHODIESTERASE SPECIFIQUE DE GMPC DANS LE TRAITEMENT DE L'IMPUISSANCE

German Title of Invention:

VERWENDUNG VON cGMP-PHOSPHODIESTERASE HEMMER ZUR BEHANDLUNG VON IMPOTENZ

SPC Number:

Dates

Filing date:

11/07/1996

Grant date:

31/05/2006

EP Publication Date:

31/05/2006

PCT Publication Date:

06/02/1997

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/05/1998

EP B1 Publication Date:

31/05/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

11/07/2016

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/07/1996

 

 

Name:

ICOS Corporation

Address:

22021 20th Avenue S.E., Bothell WA 98201, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

31/05/2006

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

DAUGAN Alain Claude-Marie, Lab.Glaxo Wellcome S.A

Address:

France (FR)

Priority

Priority Number:

9514464

Priority Date:

14/07/1995

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 31/495;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

16/07/2015

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

MDC (HENKEL PATENT)

Filing date	Document type	Number of pages